A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Published:2005-06 Issue:16_suppl Volume:23 Page:LBA7001-LBA7001
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Blumenschein G. R.¹,Khuri F.¹,Gatzemeier U.¹,Miller W. H.¹,von Pawel J.¹,Rigas J. R.¹,Herbst R. S.¹,Dziewanowska Z.¹,Negro-Vilar A.¹,Mabry M.¹

Affiliation:

1. UT M.D. Anderson Cancer Ctr, Houston, TX; Winship Cancer Institute, Emory Univ, Atlanta, GA; Hosp Grosshansdorf, Grosshansdorf, Germany; McGill Univ, Montreal, PQ, Canada; Asklepios Fachklinken Munchen Gauting, Munich, Germany; Dartmouth Medcl Sch, Lebanon, NH; Ligand Pharmaceuticals, San Diego, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.lba7001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS-Mutated Lung Cancer;Targeted Therapies for Lung Cancer;2019

2. Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2009-05-20

3. Modulation by bexarotene of mRNA expression of genes in mouse lung tumors;Molecular Carcinogenesis;2007-09-11

4. Lung Cancer;Journal of Thoracic Oncology;2007-05

5. Novel Targeted Therapies for Non–Small Cell Lung Cancer;Thoracic Surgery Clinics;2006-11